TW202317140A - 4-((r)-2-{[6-((s)-3-甲氧基-吡咯啶-1-基)-2-苯基-嘧啶-4-羰基]-胺基}-3-膦醯基-丙醯基)-哌-1-羧酸丁酯的合成方法 - Google Patents

4-((r)-2-{[6-((s)-3-甲氧基-吡咯啶-1-基)-2-苯基-嘧啶-4-羰基]-胺基}-3-膦醯基-丙醯基)-哌-1-羧酸丁酯的合成方法 Download PDF

Info

Publication number
TW202317140A
TW202317140A TW111126010A TW111126010A TW202317140A TW 202317140 A TW202317140 A TW 202317140A TW 111126010 A TW111126010 A TW 111126010A TW 111126010 A TW111126010 A TW 111126010A TW 202317140 A TW202317140 A TW 202317140A
Authority
TW
Taiwan
Prior art keywords
compound
hcl
mixture
water
amount
Prior art date
Application number
TW111126010A
Other languages
English (en)
Chinese (zh)
Inventor
妮可 伯盧莫
羅曼 卡拉奧
法比恩 菲彥
連恩 霍爾
史蒂芬 胡吉斯
史黛芬 里柏
Original Assignee
瑞士商愛杜西亞製藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑞士商愛杜西亞製藥有限公司 filed Critical 瑞士商愛杜西亞製藥有限公司
Publication of TW202317140A publication Critical patent/TW202317140A/zh

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW111126010A 2021-07-13 2022-07-12 4-((r)-2-{[6-((s)-3-甲氧基-吡咯啶-1-基)-2-苯基-嘧啶-4-羰基]-胺基}-3-膦醯基-丙醯基)-哌-1-羧酸丁酯的合成方法 TW202317140A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2021069486 2021-07-13
WOPCT/EP2021/069486 2021-07-13

Publications (1)

Publication Number Publication Date
TW202317140A true TW202317140A (zh) 2023-05-01

Family

ID=82748669

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111126010A TW202317140A (zh) 2021-07-13 2022-07-12 4-((r)-2-{[6-((s)-3-甲氧基-吡咯啶-1-基)-2-苯基-嘧啶-4-羰基]-胺基}-3-膦醯基-丙醯基)-哌-1-羧酸丁酯的合成方法

Country Status (10)

Country Link
US (1) US20240317784A1 (https=)
EP (1) EP4370525A2 (https=)
JP (1) JP2024524658A (https=)
KR (1) KR20240033005A (https=)
CN (1) CN117616033A (https=)
CA (1) CA3223733A1 (https=)
IL (1) IL309948A (https=)
MX (1) MX2024000653A (https=)
TW (1) TW202317140A (https=)
WO (1) WO2023285342A2 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2225253B1 (en) * 2007-11-29 2012-06-27 Actelion Pharmaceuticals Ltd. Phosphonic acid derivates and their use as p2y12 receptor antagonists
EP3515924B1 (en) * 2016-09-22 2021-12-15 Idorsia Pharmaceuticals Ltd Crystalline forms
MA49887A (fr) 2017-03-15 2020-06-24 Idorsia Pharmaceuticals Ltd Administration sous-cutanée d'un antagoniste du récepteur p2y12

Also Published As

Publication number Publication date
JP2024524658A (ja) 2024-07-05
KR20240033005A (ko) 2024-03-12
IL309948A (en) 2024-03-01
WO2023285342A3 (en) 2023-04-13
WO2023285342A2 (en) 2023-01-19
CN117616033A (zh) 2024-02-27
CA3223733A1 (en) 2023-01-19
EP4370525A2 (en) 2024-05-22
US20240317784A1 (en) 2024-09-26
MX2024000653A (es) 2024-01-31

Similar Documents

Publication Publication Date Title
CN107108640A (zh) 布鲁顿酪氨酸激酶抑制剂的合成
JP7157752B2 (ja) Ag-10、その中間体及びその塩の調製方法
WO1999001419A1 (en) Processes for producing 2-aminomalonic acid derivatives and 2-amino-1,3-propanediol derivatives, and intermediates for producing the derivatives
WO2017097275A1 (en) Solid forms of (2r,4s)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2- -methylpentanoic acid ethyl ester, its salts and a preparation method
WO2014093583A2 (en) Synthetic methods for preparing 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, other salt forms of this compound and intermediates thereof
JP6873053B2 (ja) タンパク質脱アセチル化阻害剤の製造方法
CZ2014502A3 (cs) Nová forma sofosbuviru a způsob její přípravy
JP2023062072A (ja) Rorガンマの阻害剤
WO2006116953A1 (en) A method for the preparation of tegaserod and slected salts thereof
EP3322704A1 (en) Crystalline forms of n-[(3-amino-3-oxetanyl)methyl]-2-(2,3-dihydro-1,1 -dioxido-1,4-benzothiazepin-4(5 h)-yl)-6-methyl-4-quinazolinamine for the treatment of respiratory syncytial virus (rsv) infections
EP3412666A1 (en) Process and intermediates for the preparation of bcl-2 inhibitors including venetoclax through reductive amination
CN105517992B (zh) 新型结晶性芳烷基胺化合物及其制造方法
JP2021524879A (ja) スガマデクスナトリウム塩の製造方法
TW202317140A (zh) 4-((r)-2-{[6-((s)-3-甲氧基-吡咯啶-1-基)-2-苯基-嘧啶-4-羰基]-胺基}-3-膦醯基-丙醯基)-哌-1-羧酸丁酯的合成方法
TWI545114B (zh) 製備聯苯基咪唑化合物之方法
US20240262805A1 (en) Method for producing compound or pharmaceutically acceptable salt thereof
KR20190125394A (ko) α-할로-아크릴산 유도체의 전이 금속-촉매 프로토탈카복실화
TWI826724B (zh) 用以製造1,5-苯并噻氮呯化合物之方法
JP4829418B2 (ja) 光学活性なハロヒドリン誘導体およびその使用方法
CN115677774B (zh) 膦酸酯衍生物及其制备方法和用途
TW200302821A (en) Process for production of optically active 2-halogeno-carboxylic acids
JP4886948B2 (ja) ビフェニルエチルアミン誘導体およびその製造方法
EP4477648A1 (en) Fluoroisoquinoline compound and production method thereof
HK40111936A (en) Method for producing compound or pharmaceutically acceptable salt thereof
CN117945945A (zh) 一种gpr139受体激动剂、其制备方法及其应用